2022
DOI: 10.1016/j.jbc.2022.101876
|View full text |Cite
|
Sign up to set email alerts
|

Entecavir competitively inhibits deoxyguanosine and deoxyadenosine phosphorylation in isolated mitochondria and the perfused rat heart

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 50 publications
(77 reference statements)
0
1
0
Order By: Relevance
“…HIV integrase inhibitors are an important class of anti-AIDS drug, which can inhibit the replication process of the retrovirus and block the integration of virus DNA and host chromosome DNA [3,4]. Combination therapy with other anti-retroviral drugs, such as Entecavir, effectively treats HIV infection, reduces drug resistance, significantly improves the quality of life and survival time of patients with AIDS, and reduces mortality [5,6]. However, AIDS patients are prone to liver damage when receiving drug treatment, especially when multiple drugs are used in combination.…”
Section: Introductionmentioning
confidence: 99%
“…HIV integrase inhibitors are an important class of anti-AIDS drug, which can inhibit the replication process of the retrovirus and block the integration of virus DNA and host chromosome DNA [3,4]. Combination therapy with other anti-retroviral drugs, such as Entecavir, effectively treats HIV infection, reduces drug resistance, significantly improves the quality of life and survival time of patients with AIDS, and reduces mortality [5,6]. However, AIDS patients are prone to liver damage when receiving drug treatment, especially when multiple drugs are used in combination.…”
Section: Introductionmentioning
confidence: 99%